AI-Driven Discovery of Brain-Penetrant Galectin-3 Inhibitors for Alzheimer’s Disease Therapy.
AI identifies FJMU1887, a Gal-3 inhibitor, enhancing cognition and reducing neuroinflammation in Alzheimer’s models. 🧠💊
June 23, 2025
Follow us
latest articles
Discover the newest research about AI innovations in 💊 Pharmacy.
Capital Rx Expands Offerings with Acquisition of Amino Health
Capital Rx acquires Amino Health, enhancing care navigation with Judi Care. This platform aims to simplify healthcare access and costs. 🏥💊
June 11, 2025
Collaboration Between Better Meds and BD to Enhance Medication Management
Better Meds and BD collaborate to enhance medication management with automated dispensing cabinets, improving safety and efficiency in hospitals. 🏥💊
June 11, 2025
Exploring the potential of anticancer peptides as therapeutic agents for cancer treatment.
Anticancer peptides show promise in targeting tumors with low toxicity. Key findings from PubMed article reviewed. 🧬💊
May 30, 2025
Coreline Soft Secures AI Imaging Contracts with NHS and Boehringer Ingelheim
Coreline Soft secures AI imaging contracts with NHS and Boehringer Ingelheim, enhancing medical image analysis in healthcare. 🏥📊
May 30, 2025
Enhancing search strategies for systematic reviews on drug Harms: An evaluation of the utility of ChatGPT in error detection and keyword generation.
ChatGPT enhances drug harm reviews: 49% keyword recreation, 0.17 Jaccard similarity. Effective error detection tool! 📊💊
May 30, 2025
Evaluation of Diagnostic Recommendations Embedded in Medication Alerts: Prospective Single-Arm Interventional Study.
Evaluating machine learning in outpatient care: 2.28% alert rate, 56.55% acceptance. Key findings on diagnostic recommendations. 📊💊
May 28, 2025
New Prescription Tracking Feature Launched in NHS App
NHS App introduces prescription tracking feature 📱💊, allowing real-time updates to reduce pharmacy visits and calls.
May 24, 2025
Serve You Rx Partners with Amazon Pharmacy for Home Delivery Services
Serve You Rx partners with Amazon Pharmacy for home delivery of maintenance medications. Members gain 24/7 pharmacist access and transparent pricing. 📦💊
May 3, 2025
Patient Experience with Intranasal Esketamine in Treatment-Resistant Depression: Insights from a Multicentric Italian Study (REAL-ESKperience).
Patient experiences with intranasal esketamine show 88.4% report improved quality of life in treatment-resistant depression. 🌟🧠
April 26, 2025